Neuromodulation techniques
The subject matter of the present disclosure generally relates to techniques for applying mechanical or ultrasound energy to a region of interest in a subject to induce modulation of one or more nerve pathways. The region of interest may include at least a portion of a nerve ganglion.
1. A method, comprising:
applying non-invasive and non-ablative or ultrasound energy using an ultrasound transducer directly to at least a portion of a nerve plexus or at least a portion of a ganglion in a subject to induce modulation of one or more nerve pathways;
receiving image data from the ultrasound transducer; and
determining that the modulation has been induced based on the image data.
2. The method of claim 1 , wherein the at least the portion of the nerve plexus or the at least the portion of the ganglion is anatomically selected or image guided via a controller associated with the ultrasound transducer and using the image data.
3. The method of claim 1 , wherein the method comprises applying the ultrasound energy to at least the portion of the nerve plexus, and wherein the nerve plexus is a peripheral nerve plexus.
4. The method of claim 1 , wherein the method comprises applying the ultrasound energy directly to at least the portion of the ganglion, and wherein the ganglion is a peripheral ganglion.
5. The method of claim 1 , wherein the modulation of the one or more nerve pathways comprises activation or deactivation of a first nerve pathway of the one or more nerve pathways and a lack of activation or deactivation of a second nerve pathway of the one or more nerve pathways.
6. The method of claim 5 , wherein the first nerve pathway is an anti-inflammatory pathway and the second nerve pathway is a glucose regulatory pathway.
7. The method of claim 5 , wherein the first nerve pathway is a glucose regulatory pathway and the second nerve pathway is an anti-inflammatory pathway.
8. The method of claim 5 , wherein the first nerve pathway is associated with a change in concentration of a cytokine, a hormone, or a neurotransmitter.
9. The method of claim 1 , wherein the modulation of the one or more nerve pathways results in respective changes in concentration of one or more molecules comprising glucose, insulin, tumor necrosis factor (TNF), acetylcholine, norepinephrine, or dopamine, or a combination thereof.
10. The method of claim 1 , wherein the subject is a subject with a metabolic disorder, and wherein modulation causes a change in a circulating glucose concentration of the subject relative to a baseline concentration.
11. A method, comprising:
applying non-invasive and non-ablative mechanical or extracorporeal ultrasound energy directly to at least a portion of a nerve plexus or at least a portion of a ganglion in a subject to induce a first modulation of one or more first nerve pathways and a lack of a second modulation of one or more second nerve pathways, wherein inducing modulation of the one or more first nerve pathways comprises applying a plurality of energy pulses to stimulate synapses in the portion of the nerve plexus or the portion of the ganglion to release neurotransmitters; and
assessing an effect of stimulating the synapses.
12. The method of claim 11 , wherein the one or more first nerve pathways comprise a first anti-inflammatory pathway, a first glucose regulatory pathway, a first insulin production pathway, a first neuro-immune pathway, or a first dopamine production pathway, or a combination thereof.
13. The method of claim 12 , wherein the one or more second nerve pathways comprise a second anti-inflammatory pathway, a second glucose regulatory pathway, a second insulin production pathway, a second neuro-immune pathway, or a second dopamine production pathway, or a combination thereof.
14. The method of claim 11 , wherein the one or more first nerve pathways is associated with a change in concentration of a cytokine, a hormone, or a neurotransmitter in the subject, and wherein the assessing comprises receiving real-time concentration inputs to determine the change in concentration.
15. The method of claim 11 , wherein the first modulation of the one or more first nerve pathways results in respective changes in concentration of one or more molecules comprising glucose, insulin, tumor necrosis factor (TNF), acetylcholine, norepinephrine, or dopamine, or a combination thereof.
16. A system, comprising:
an energy application device configured to apply non-invasive and non-ablative mechanical or ultrasound energy directly to at least a portion of a nerve plexus or at least a portion of a ganglion in a subject to induce modulation of one or more nerve pathways to cause a change in circulating glucose levels in the subject; and
a controller configured to spatially select the at least the portion of the nerve plexus or the at least the portion of the ganglion.
17. The system of claim 16 , wherein the energy application device is configured to be positioned above a selected region of the at least the portion of the nerve plexus or the at least the portion of the ganglion via image guidance or anatomical selection before applying the mechanical or ultrasound energy.
18. The system of claim 16 , wherein the energy application device is an ultrasound transducer that applies the non-invasive and non-ablative mechanical or ultrasound energy at a temporal average intensity of less than 35 W/cm 2 .
19. The method of claim 1 , wherein the non-invasive and non-ablative mechanical or ultrasound energy is applied to the portion of the nerve plexus or the portion of the ganglion at a temporal average intensity is less than 35 W/cm 2 .
20. The method of claim 11 , further comprising:
changing a frequency of the plurality of energy pulses based on the assessing.